Annual Retained Earnings
-$265.93 M
-$51.06 M-23.76%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual retained earnings is -$265.93 million, with the most recent change of -$51.06 million (-23.76%) on December 31, 2023.
- During the last 3 years, VIRX annual retained earnings has fallen by -$215.02 million (-422.31%).
- VIRX annual retained earnings is now -422.31% below its all-time high of -$50.91 million, reached on December 31, 2020.
Performance
VIRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$295.46 M
-$10.55 M-3.70%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly retained earnings is -$295.46 million, with the most recent change of -$10.55 million (-3.70%) on September 30, 2024.
- Over the past year, VIRX quarterly retained earnings has dropped by -$29.52 million (-11.10%).
- VIRX quarterly retained earnings is now -480.29% below its all-time high of -$50.91 million, reached on December 31, 2020.
Performance
VIRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VIRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.8% | -11.1% |
| 3 y3 years | -422.3% | -11.1% |
| 5 y5 years | -422.3% | -11.1% |
VIRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.5% | at low | -78.3% | at low |
| 5 y | 5-year | -422.3% | at low | -480.3% | at low |
| alltime | all time | -422.3% | at low | -480.3% | at low |
Viracta Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$295.46 M(+3.7%) |
| Jun 2024 | - | -$284.90 M(+3.6%) |
| Mar 2024 | - | -$275.07 M(+3.4%) |
| Dec 2023 | -$265.93 M(+23.8%) | -$265.93 M(+5.5%) |
| Sep 2023 | - | -$252.17 M(+5.3%) |
| Jun 2023 | - | -$239.57 M(+5.5%) |
| Mar 2023 | - | -$227.08 M(+5.7%) |
| Dec 2022 | -$214.87 M | -$214.87 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$204.55 M(+9.5%) |
| Jun 2022 | - | -$186.81 M(+6.0%) |
| Mar 2022 | - | -$176.22 M(+6.4%) |
| Dec 2021 | -$165.68 M(+225.4%) | -$165.68 M(+7.4%) |
| Sep 2021 | - | -$154.23 M(+10.7%) |
| Jun 2021 | - | -$139.32 M(+7.0%) |
| Mar 2021 | - | -$130.15 M(+155.6%) |
| Dec 2020 | -$50.91 M | -$50.91 M |
FAQ
- What is Viracta Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Viracta Therapeutics?
- What is Viracta Therapeutics annual retained earnings year-on-year change?
- What is Viracta Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly retained earnings year-on-year change?
What is Viracta Therapeutics annual retained earnings?
The current annual retained earnings of VIRX is -$265.93 M
What is the all time high annual retained earnings for Viracta Therapeutics?
Viracta Therapeutics all-time high annual retained earnings is -$50.91 M
What is Viracta Therapeutics annual retained earnings year-on-year change?
Over the past year, VIRX annual retained earnings has changed by -$51.06 M (-23.76%)
What is Viracta Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VIRX is -$295.46 M
What is the all time high quarterly retained earnings for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly retained earnings is -$50.91 M
What is Viracta Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VIRX quarterly retained earnings has changed by -$29.52 M (-11.10%)